Products
-
Helicobacter Pylori Antigen
This kit is used for in vitro qualitative detection of Helicobacter pylori antigen in human stool samples. The test results are for the auxiliary diagnosis of Helicobacter pylori infection in clinical gastric disease.
-
Group A Rotavirus and Adenovirus antigens
This kit is used for in vitro qualitative detection of group A rotavirus or adenovirus antigens in stool samples of infants and young children.
-
Dengue NS1 Antigen, IgM/IgG Antibody Dual
This kit is used for in vitro qualitative detection of dengue NS1 antigen and IgM/IgG antibody in serum, plasma and whole blood by immunochromatography, as an auxiliary diagnosis of dengue virus infection.
-
Luteinizing Hormone (LH)
The product is used for in vitro qualitative detection of the level of Luteinizing hormone in human urine.
-
SARS-CoV-2 Nucleic Acid
The kit is intended for In Vitro qualitatively detecting the ORF1ab gene and N gene of SARS-CoV-2 in specimen of pharyngeal swabs from suspected cases, patients with suspected clusters or other persons under investigation of SARS-CoV-2 infections.
-
SARS-CoV-2 influenza A influenza B Nucleic Acid Combined
This kit is suitable for in vitro qualitative detection of SARS-CoV-2, influenza A and influenza B nucleic acid of the nasopharyngeal swab and oropharyngeal swab samples which of the people who were suspected infection of SARS-CoV-2, influenza A and influenza B.
-
Real-time fluorescent RT-PCR kit for detecting SARS-CoV-2
This kit is intended to in vitro qualitatively detect the ORF1ab and N genes of novel coronavirus (SARS-CoV-2) in the nasopharyngeal swab and oropharyngeal swab collected from cases and clustered cases suspected with novel coronavirus-infected pneumonia and others required for the diagnosis or differential diagnosis of novel coronavirus infection.
-
SARS-CoV-2 IgM/IgG Antibody
This kit is intended for in vitro qualitative detection of SARS-CoV-2 IgG antibody in human samples of serum/plasma, venous blood and fingertip blood, including SARS-CoV-2 IgG antibody in naturally infected and vaccine-immunized populations.
